• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑氟脱氧葡萄糖(FDG)PET 显像在痴呆中的应用。

Brain fluorodeoxyglucose (FDG) PET in dementia.

机构信息

Department of Radiology, National Center for Geriatrics and Gerontology, Japan; Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Japan.

Department of Radiology, National Center for Geriatrics and Gerontology, Japan.

出版信息

Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11.

DOI:10.1016/j.arr.2016.02.003
PMID:26876244
Abstract

The purpose of this article is to present a selective and concise summary of fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG PET is used to visualize a downstream topographical marker that indicates the distribution of neural injury or synaptic dysfunction, and can identify distinct phenotypes of dementia due to Alzheimer's disease (AD), Lewy bodies, and frontotemporal lobar degeneration. AD dementia shows hypometabolism in the parietotemporal association area, posterior cingulate, and precuneus. Hypometabolism in the inferior parietal lobe and posterior cingulate/precuneus is a predictor of cognitive decline from mild cognitive impairment (MCI) to AD dementia. FDG PET may also predict conversion of cognitively normal individuals to those with MCI. Age-related hypometabolism is observed mainly in the anterior cingulate and anterior temporal lobe, along with regional atrophy. Voxel-based statistical analyses, such as statistical parametric mapping or three-dimensional stereotactic surface projection, improve the diagnostic performance of imaging of dementias. The potential of FDG PET in future clinical and methodological studies should be exploited further.

摘要

本文旨在对氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)在痴呆成像中的应用进行选择性和简明的综述。FDG PET 用于可视化指示神经损伤或突触功能障碍分布的下游拓扑标志物,并可因阿尔茨海默病(AD)、路易体和额颞叶变性而识别出不同的痴呆表型。AD 痴呆症表现为顶颞联合区、后扣带回和楔前叶的代谢低下。下顶叶和后扣带回/楔前叶的代谢低下是从轻度认知障碍(MCI)到 AD 痴呆症认知下降的预测指标。FDG PET 也可预测认知正常个体向 MCI 的转变。与年龄相关的代谢低下主要发生在前扣带回和前颞叶,同时伴有区域性萎缩。基于体素的统计分析,如统计参数映射或三维立体定向表面投影,可提高痴呆症影像学的诊断性能。应进一步挖掘 FDG PET 在未来临床和方法学研究中的潜力。

相似文献

1
Brain fluorodeoxyglucose (FDG) PET in dementia.脑氟脱氧葡萄糖(FDG)PET 显像在痴呆中的应用。
Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11.
2
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.轻度认知障碍中的脑代谢图谱可预测发展为痴呆症的异质性。
Neuroimage Clin. 2014 Dec 5;7:187-94. doi: 10.1016/j.nicl.2014.12.004. eCollection 2015.
3
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.语义性痴呆和阿尔茨海默病中淀粉样斑块与脑葡萄糖代谢的成像
Neuroimage. 2008 Jan 15;39(2):619-33. doi: 10.1016/j.neuroimage.2007.09.020. Epub 2007 Sep 21.
4
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.用于轻度认知障碍向阿尔茨海默病转化预后评估的脑氟代脱氧葡萄糖正电子发射断层显像统计单受试者分析的优化
J Alzheimers Dis. 2016;49(4):945-959. doi: 10.3233/JAD-150814.
5
Positron emission tomography imaging in dementia.痴呆症中的正电子发射断层扫描成像
Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129.
6
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.18F-FDG和淀粉样蛋白PET的视觉分析与全自动分析对轻度认知障碍患者阿尔茨海默病所致痴呆的预测作用
J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.
7
The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.使用基于个体的 FDG-PET 感兴趣区容积预测从轻度认知障碍到痴呆的转化。
BMC Med Imaging. 2024 Mar 28;24(1):75. doi: 10.1186/s12880-024-01256-x.
8
18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.18F-FDG PET在额颞叶痴呆中的表现:29例患者的SPM分析
J Nucl Med. 2005 Feb;46(2):233-9.
9
Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.与路易体痴呆和阿尔茨海默病相比,后皮质萎缩中脑葡萄糖代谢区域的综合征特异性模式——一项[F-18] - FDG PET研究。
J Neuroimaging. 2015 Mar-Apr;25(2):281-288. doi: 10.1111/jon.12104. Epub 2014 Mar 5.
10
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.阿尔茨海默病谱系中区域氟脱氧葡萄糖代谢与日常生活工具性活动
J Alzheimers Dis. 2014;42(1):291-300. doi: 10.3233/JAD-131796.

引用本文的文献

1
Alzheimer's Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2).阿尔茨海默病的致病机制:通过核因子红细胞2相关因子2(Nrf2)连接氧化还原稳态与线粒体相关代谢途径
Antioxidants (Basel). 2025 Jul 1;14(7):812. doi: 10.3390/antiox14070812.
2
Association of Reduced Brain Metabolism With Motor Function and Survival in Amyotrophic Lateral Sclerosis Patients With Neurofilament Heavy (NEFH) Gene Mutation.脑代谢降低与神经丝重链(NEFH)基因突变的肌萎缩侧索硬化患者运动功能及生存的关系。
Eur J Neurol. 2025 Jul;32(7):e70261. doi: 10.1111/ene.70261.
3
Development of a Diagnostic Prediction Model for Post-Stroke Cognitive Impairment in Acute Large Vessel Occlusion Stroke Using Multimodal MRI and PET/CT: A Study Protocol.
使用多模态MRI和PET/CT开发急性大血管闭塞性卒中后认知障碍的诊断预测模型:一项研究方案
Brain Behav. 2025 Jun;15(6):e70613. doi: 10.1002/brb3.70613.
4
Current Methods in Clinical Alzheimer's Disease Research and Diagnosis.临床阿尔茨海默病研究与诊断的当前方法
Mol Diagn Ther. 2025 Jun 7. doi: 10.1007/s40291-025-00789-3.
5
Brain metabolic imaging-based model identifies cognitive stability in prodromal Alzheimer's disease.基于脑代谢成像的模型可识别前驱性阿尔茨海默病的认知稳定性。
Sci Rep. 2025 May 17;15(1):17187. doi: 10.1038/s41598-025-02039-2.
6
Rock inhibitors in Alzheimer's disease.阿尔茨海默病中的岩石抑制剂。 (不过这里“rock inhibitors”表述不太准确,可能是“tau inhibitors”之类的,按给定文本翻译是这样)
Front Aging. 2025 Mar 20;6:1547883. doi: 10.3389/fragi.2025.1547883. eCollection 2025.
7
Biomarkers in Alzheimer's disease: Emerging trends and clinical implications.阿尔茨海默病中的生物标志物:新趋势与临床意义
Chin Med J (Engl). 2025 May 5;138(9):1009-1012. doi: 10.1097/CM9.0000000000003579. Epub 2025 Apr 1.
8
Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.长期接触合成大麻素可改善Tg4-42阿尔茨海默病小鼠的认知能力并增加其运动活性。
J Alzheimers Dis Rep. 2025 Feb 27;9:25424823241306770. doi: 10.1177/25424823241306770. eCollection 2025 Jan-Dec.
9
Age-Related Changes in Caudate Glucose Metabolism: Insights from Normative Modeling Study in Healthy Subjects.尾状核葡萄糖代谢的年龄相关变化:来自健康受试者规范建模研究的见解
Metabolites. 2025 Jan 22;15(2):67. doi: 10.3390/metabo15020067.
10
Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET.α-突触核蛋白对阿尔茨海默病连续体中葡萄糖代谢的影响:α-突触核蛋白种子扩增试验和氟代脱氧葡萄糖正电子发射断层扫描分析
Alzheimers Dement. 2025 Feb;21(2):e14571. doi: 10.1002/alz.14571.